Trial reportBMC psychiatry2017
Feasibility and efficacy of shared decision making for first-admission schizophrenia: a randomized clinical trial.
Trial report in BMC psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01869660 (Shared Decision Making for Patients With First-admission Schizophrenia), which is not on this map. Cited by 14 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Shared Decision Making for Patients With First-admission Schizophrenia: a Randomized Controlled Trial
Who cites it
14 citing papers in PubMed, 5 syntheses or guidelines pooled it, 22 citations in OpenAlex.
- Supported Decision-Making Interventions in Mental Healthcare: A Systematic Review of Evidence on the Outcomes for People With Mental Ill Health.Health expectations : an international journal of public participation in health care and health policy · 2024Pooled it
- Shifting Perspectives on the Challenges of Shared Decision Making in Mental Health Care.Community mental health journal · 2024Pooled it
- Trends, challenges, and priorities for shared decision making in mental health: The first umbrella review.The International journal of social psychiatry · 2023Pooled it
- Shared decision-making interventions for people with mental health conditions.The Cochrane database of systematic reviews · 2022Pooled it
- A Systematic Review of Shared Decision-Making Interventions for Service Users With Serious Mental Illnesses: State of the Science and Future Directions.Psychiatric services (Washington, D.C.) · 2021Pooled it
- Trial
- Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia.Neuropsychopharmacology reports · 2023Article
- How do patients and families evaluate attitude of psychiatrists in Japan?: quantitative content analysis of open-ended items of patient responses from a large-scale questionnaire survey.BMC psychiatry · 2023Article
- Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature.Frontiers in psychiatry · 2022Review
- NICE shared decision making guidelines and mental health: challenges for research, practice and implementation.BJPsych open · 2021Article
- Relationship between satisfaction with mental health services, personal recovery and quality of life among service users with psychosis: a cross-sectional study.BMC health services research · 2021Observational
- Shared decision making for adults with severe mental illness: A concept analysis.Japan journal of nursing science : JJNS · 2020Review
- Treating Schizophrenia: Open Conversations and Stronger Relationships Through Psychoeducation and Shared Decision-Making.Frontiers in psychiatry · 2020Article
- The role of shared decision-making in improving adherence to pharmacological treatments in patients with schizophrenia: a clinical review.Annals of general psychiatry · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe feasibility of shared decision making (SDM) for patients with schizophrenia remains controversial due to the assumed inability of patients to cooperate in treatment decision making. This study evaluated the feasibility and efficacy of SDM in patients upon first admission for schizophrenia.
methodsThis was a randomized, parallel-group, two-arm, open-label, single-center study conducted in an acute psychiatric ward of Numazu Chuo Hospital, Japan. Patients with the diagnosis of schizophrenia upon their first admission were randomized into a SDM intervention group or a usual treatment group in a 1:1 ratio. The primary outcome was patient satisfaction at discharge. The secondary outcomes were attitudes toward medication at discharge and treatment continuation at 6 months after discharge.
resultsTwenty-four patients were randomly assigned. The trial was prematurely terminated due to slow enrollment. At discharge, the mean score on satisfaction was 23.7 in the SDM group and 22.1 in the usual care group (unadjusted mean difference: 1.6; 95% CI: -5.2 to 2.0). Group differences were not observed in attitude toward medication and treatment continuation. There was no statistically significant difference between the groups for the mean Global Assessment of Functioning score at discharge or length of stay as safety endpoint.
conclusionsNo statistical differences were found between the SDM group and usual care group in the efficacy outcomes and safety endpoints. Large trials are needed to confirm the efficacy of the SDM program upon first admission for schizophrenia.
trial registrationThe study has been registered with ClinicalTrials.gov as NCT01869660 (registered 27 May, 2013).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.